The results indicated that BIRC2 knockdown in conjunction with anti‐PD‐1 treatment significantly inhibited tumour growth and reduced tumour volume (Figure 9B,C), and prolonged mouse survival (Figure 9D). The gene discussed is BIRC2; the disease is neoplasm.